Gyre Therapeutics Inc. (GYRE)
NASDAQ · Healthcare
Gyre Therapeutics Inc. Shareholder Equity 2009–2025
Gyre Therapeutics Inc. annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Gyre Therapeutics Inc. shareholder equity as of December 31, 2025: 106.0M, a 67.46% increase year-over-year.
- Gyre Therapeutics Inc. shareholder equity for 2025 were 106.0M, a 67.46% increase from 2024.
- Gyre Therapeutics Inc. shareholder equity for 2024 were 63.3M, a 500.04% decrease from 2023.
- Gyre Therapeutics Inc. shareholder equity for 2023 were -15.8M, a 137.22% decrease from 2022.
- Gyre Therapeutics Inc. shareholder equity for 2022 were 42.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Gyre Therapeutics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $106 |
| 2024 | $63 |
| 2023 | $-16 |
| 2022 | $43 |
| 2021 | $41 |
| 2020 | $76 |
| 2018 | $120 |
| 2017 | $31 |
| 2014 | $-109 |
| 2013 | $-103 |
| 2012 | $-93 |
| 2011 | $174 |
| 2010 | $92 |
Gyre Therapeutics Inc. Shareholder Equity — FAQ
Gyre Therapeutics Inc. (GYRE) shareholder equity over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GYRE's shareholder equity history?
The chart and table above show Gyre Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.